波兰免疫性血小板减少症的诊断和治疗

Q4 Medicine

Hematologia Pub Date : 2022-10-20 DOI:10.5603/hcp.a2022.0013

P. Malecki, S. Grosicki

{"title":"波兰免疫性血小板减少症的诊断和治疗","authors":"P. Malecki, S. Grosicki","doi":"10.5603/hcp.a2022.0013","DOIUrl":null,"url":null,"abstract":"Immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by an isolated platelet count of less than 100,000/μL caused by destruction and reduced production of platelets. Systemic steroid therapy is a mainstay of first-line treatment; however, additional treatment lines are usually necessary due to the very high recurrence rate after therapy completion and steroid resistance. Standard treatment options for steroid resistance or steroid dependence include splenectomy, rituximab or thrombopoietin receptor agonists. The article presents current data on the diagnosics and therapy of ITP, considering the limited access to some forms of treatment in Poland","PeriodicalId":38988,"journal":{"name":"Hematologia","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis and treatment of immune thrombocytopenia in Poland\",\"authors\":\"P. Malecki, S. Grosicki\",\"doi\":\"10.5603/hcp.a2022.0013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by an isolated platelet count of less than 100,000/μL caused by destruction and reduced production of platelets. Systemic steroid therapy is a mainstay of first-line treatment; however, additional treatment lines are usually necessary due to the very high recurrence rate after therapy completion and steroid resistance. Standard treatment options for steroid resistance or steroid dependence include splenectomy, rituximab or thrombopoietin receptor agonists. The article presents current data on the diagnosics and therapy of ITP, considering the limited access to some forms of treatment in Poland\",\"PeriodicalId\":38988,\"journal\":{\"name\":\"Hematologia\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/hcp.a2022.0013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/hcp.a2022.0013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

免疫性血小板减少症(ITP)是一种获得性自身免疫性疾病，其特征是孤立血小板计数低于100,000/μL，由血小板破坏和血小板生成减少引起。全身类固醇治疗是一线治疗的主要方法;然而，由于治疗完成后复发率非常高和类固醇抵抗，通常需要额外的治疗方案。类固醇抵抗或类固醇依赖的标准治疗方案包括脾切除术、利妥昔单抗或血小板生成素受体激动剂。本文介绍了ITP诊断和治疗的当前数据，考虑到波兰获得某些形式的治疗的机会有限

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Diagnosis and treatment of immune thrombocytopenia in Poland

Immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by an isolated platelet count of less than 100,000/μL caused by destruction and reduced production of platelets. Systemic steroid therapy is a mainstay of first-line treatment; however, additional treatment lines are usually necessary due to the very high recurrence rate after therapy completion and steroid resistance. Standard treatment options for steroid resistance or steroid dependence include splenectomy, rituximab or thrombopoietin receptor agonists. The article presents current data on the diagnosics and therapy of ITP, considering the limited access to some forms of treatment in Poland

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hematologia Medicine-Oncology

自引率

0.00%

发文量

审稿时长

4 weeks

期刊介绍： Hematology is the quarterly under auspices of the Institute of Hematology and Transfusion Medicine. The journal is addressed to hematologists, oncologists and also internists. It contains the overview/review articles, case reports, essays, including reports from the scientific and educational conferences as well as test questions on hematology. Journal of the Institute of Hematology and Transfusiology.